Abstract: A conjugate, in which an antibody or a fragment thereof having immunological reactivity with a CAPRIN-1 protein that has an amino acid sequence represented by any one of the even numbered SEQ ID NOS: 2 to 30 or an amino acid sequence having 80% or more sequence identity with the aforesaid amino acid sequence is linked to a benzodiazepine, is useful as an antibody-drug conjugate (ADC).
| # | Name | Date |
|---|---|---|
| 1 | 202417096521-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [06-12-2024(online)].pdf | 2024-12-06 |
| 2 | 202417096521-STATEMENT OF UNDERTAKING (FORM 3) [06-12-2024(online)].pdf | 2024-12-06 |
| 5 | 202417096521-Sequence Listing in PDF [06-12-2024(online)].pdf | 2024-12-06 |
| 6 | 202417096521-REQUEST FOR EXAMINATION (FORM-18) [06-12-2024(online)].pdf | 2024-12-06 |
| 7 | 202417096521-PROOF OF RIGHT [06-12-2024(online)].pdf | 2024-12-06 |
| 8 | 202417096521-POWER OF AUTHORITY [06-12-2024(online)].pdf | 2024-12-06 |
| 9 | 202417096521-FORM 18 [06-12-2024(online)].pdf | 2024-12-06 |
| 10 | 202417096521-FORM 1 [06-12-2024(online)].pdf | 2024-12-06 |
| 11 | 202417096521-DECLARATION OF INVENTORSHIP (FORM 5) [06-12-2024(online)].pdf | 2024-12-06 |
| 12 | 202417096521-COMPLETE SPECIFICATION [06-12-2024(online)].pdf | 2024-12-06 |
| 13 | 202417096521-certified copy of translation [09-12-2024(online)].pdf | 2024-12-09 |
| 14 | 202417096521-MARKED COPIES OF AMENDEMENTS [18-12-2024(online)].pdf | 2024-12-18 |
| 15 | 202417096521-FORM 13 [18-12-2024(online)].pdf | 2024-12-18 |
| 16 | 202417096521-AMMENDED DOCUMENTS [18-12-2024(online)].pdf | 2024-12-18 |
| 17 | 202417096521-FORM 3 [30-05-2025(online)].pdf | 2025-05-30 |